TrialX
Image

Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19

Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19

Recruiting
18-75 years
All
Phase N/A

Overview

This study is a multi-center randomized, controlled, and blinded clinical trial study that will be performed in four medical-educational centers. In this study, the samples will be selected from among patients with SARS-CoV-2 as easy access and based on entry criteria and will be randomly divided into two groups, including a control group and an intervention group. The study will be conducted in four medical centers. From each center, 56 definitive Corona patients will be selected, who will be randomly divided into two groups of 28, for a total of 224 patients will enter the study. In the intervention group, in addition to receiving the test spray, Patients will also receive standard treatment

Eligibility

Inclusion Criteria:

  • Patients with COVID-19 who are hospitalized
  • Conscious consent to participate in the study
  • Patients 18 to 75 years of age with COVID-19 who have been diagnosed with PCR.
  • Strong clinical suspicion of covid 19 with positive findings in CT Scan
  • Shortness of breath

Exclusion Criteria:

  • Patients with HIV
  • Patients with cancer undergoing chemotherapy
  • Patients receiving Immune Mediators
  • Patients need hospitalization in the intensive care unit
  • Patients with uncontrolled heart, kidney or liver failure
  • Pregnant or lactating women
  • Intolerance to the drugs used in this study (symptoms such as diarrhea, nausea, vomiting and respiratory problems)

Study details
    Covid 19

NCT04463420

Baqiyatallah Medical Sciences University

16 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.